What does Arbutus Biopharma Corp (ABUS) do?

Arbutus Biopharma Corp (ABUS) is a publicly traded company in the Healthcare sector.

What sector does ABUS operate in?

Arbutus Biopharma Corp operates in the Healthcare, specifically within the Pharmaceutical Preparations industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find ABUS earnings analysis?

AlphaOS publishes an earnings intelligence page for Arbutus Biopharma Corp (ABUS) covering results, guidance context, and AI-assisted analysis. See /stocks/ABUS/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

ABUS

Arbutus Biopharma Corp

Healthcare · Pharmaceutical Preparations

$4.85Sep 25, 2026

AI confidence 70% · refreshes every 15s during session

Investment Snapshot

Weak evidence · 1 source

Why it matters

Arbutus Biopharma Corp shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -91% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -91% YoY in Q2 FY2026

Pipeline evidence · 1d ago

ABUS's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on ABUS.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full ABUS earnings analysis

Reported figures for Arbutus Biopharma Corp — research only, not investment advice.

Revenue YoY: -90.6%
EPS YoY: -400.0%

Latest Intelligence

Updated September 28, 2026

What happened recently for Arbutus Biopharma Corp (ABUS) — events, not interpretation.

Event: Reported Q2 2026 revenue -91% YoY.
Also: Last session September 25, 2026 at $4.85.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Loading earnings intelligence…

Arbutus Biopharma Corp (ABUS)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Arbutus Biopharma Corp — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceutical Preparations
Market cap:: $959.56M
Revenue:: $1.01M

ABUS earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Arbutus Biopharma Corp through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.